Literature DB >> 30256312

Term Elective Cesarean Delivery and Offspring Infectious Morbidity: A Population-Based Cohort Study.

Tamar Wainstock1, Asnat Walfisch2, Ilana Shoham-Vardi1, Idit Segal3, Ruslan Sergienko1, Daniella Landau4, Eyal Sheiner2.   

Abstract

BACKGROUND: Studies have found associations between delivery mode and offspring long-term health. We aimed to study the possible association between delivery mode and the risk for long-term infectious diseases of the offspring during a follow-up period of up of 18 years.
METHODS: A population-based cohort analysis was performed comparing different subtypes of infectious morbidity leading to hospitalization among children, based on delivery mode (vaginal vs. elective cesarean). Data on pregnancy course and outcome, delivery mode and later offspring hospitalizations were available from a single tertiary center. All singleton uncomplicated deliveries and pregnancies between the years 1991 and 2014 were included in the analysis. Kaplan-Meier and multivariable Weibull survival models were applied to adjust for differences in follow-up time between the study groups and confounders.
RESULTS: During the study period, 138,910 newborns met the inclusion criteria: 13,206 (9.5%) were delivered by elective cesarean delivery, and 125,704 (91.5%) were delivered vaginally. During the follow-up period (median: 10.22 years), 13,054 (9.4%) were hospitalized (at least once) with infectious morbidity: 12.0% and 9.1% among the cesarean and vaginally delivered children, respectively (Relative Risk: 1.36; 95% confidence interval: 1.28-1.43; incidence density rates for first hospitalization were 15.22/1000 person-years and 9.06/1000 person-years among cesarean and vaginally delivered children, respectively; Kaplan-Meier log rank P < 0.001). The association between cesarean delivery and long-term pediatric infectious morbidity remained significant in the multivariable model, controlling for confounding variables (adjusted hazard ratio: 1.18; 95% confidence interval: 1.11-1.25; P < 0.001).
CONCLUSIONS: Children delivered by elective cesarean section are at an increased risk for hospitalization with pediatric infectious morbidity when compared with vaginally delivered children.

Entities:  

Mesh:

Year:  2019        PMID: 30256312     DOI: 10.1097/INF.0000000000002197

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  5 in total

Review 1.  Are there adverse outcomes for child health and development following caesarean section delivery? Can we justify using elective caesarean section to prevent obstetric pelvic floor damage?

Authors:  Jennifer King
Journal:  Int Urogynecol J       Date:  2021-04-20       Impact factor: 2.894

2.  Association of birth mode of delivery with infant faecal microbiota, potential pathobionts, and short chain fatty acids: a longitudinal study over the first year of life.

Authors:  N T Mueller; M K Differding; T Østbye; C Hoyo; S E Benjamin-Neelon
Journal:  BJOG       Date:  2021-02-01       Impact factor: 7.331

3.  Mode of birth and risk of infection-related hospitalisation in childhood: A population cohort study of 7.17 million births from 4 high-income countries.

Authors:  Jessica E Miller; Raphael Goldacre; Hannah C Moore; Justin Zeltzer; Marian Knight; Carole Morris; Sian Nowell; Rachael Wood; Kim W Carter; Parveen Fathima; Nicholas de Klerk; Tobias Strunk; Jiong Li; Natasha Nassar; Lars H Pedersen; David P Burgner
Journal:  PLoS Med       Date:  2020-11-19       Impact factor: 11.069

4.  Maternal Obesity and Offspring Long-Term Infectious Morbidity.

Authors:  Gil Gutvirtz; Tamar Wainstock; Daniella Landau; Eyal Sheiner
Journal:  J Clin Med       Date:  2019-09-14       Impact factor: 4.241

5.  Delivery mode and altered infant growth at 1 year of life in India.

Authors:  Giridhara R Babu; Noel T Mueller; Melissa Glenda Lewis; Anjaly Krishnan; Eunice Lobo; R Deepa; Sonalini Khetrapal; Sara E Benjamin-Neelon
Journal:  Pediatr Res       Date:  2021-03-02       Impact factor: 3.756

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.